Monogram Orthopaedics Current Debt
| MGRM Stock | 2.66 0.09 3.50% |
At this time, Monogram Orthopaedics' Short and Long Term Debt Total is very stable compared to the past year. As of the 15th of December 2024, Net Debt To EBITDA is likely to grow to 0.82, while Short Term Debt is likely to drop about 121.9 K. . Monogram Orthopaedics' financial risk is the risk to Monogram Orthopaedics stockholders that is caused by an increase in debt.
Debt Ratio | First Reported 2010-12-31 | Previous Quarter 0.93 | Current Value 0.89 | Quarterly Volatility 0.91142569 |
Monogram |
Monogram Orthopaedics Financial Rating
Monogram Orthopaedics Common financial ratings play a critical role in determining how much Monogram Orthopaedics have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Monogram Orthopaedics' borrowing costs.| Piotroski F Score | 3 | Frail | View |
| Beneish M Score | (1.16) | Possible Manipulator | View |
Monogram Orthopaedics Total Assets Over Time
Monogram Orthopaedics Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Monogram Orthopaedics uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Monogram Orthopaedics Debt Ratio | 89.0 |
Monogram Short Long Term Debt Total
Short Long Term Debt Total |
|
Understaning Monogram Orthopaedics Use of Financial Leverage
Leverage ratios show Monogram Orthopaedics' total debt position, including all outstanding obligations. In simple terms, high financial leverage means that the cost of production, along with the day-to-day running of the business, is high. Conversely, lower financial leverage implies lower fixed cost investment in the business, which is generally considered a good sign by investors. The degree of Monogram Orthopaedics' financial leverage can be measured in several ways, including ratios such as the debt-to-equity ratio (total debt / total equity), or the debt ratio (total debt / total assets).
| Last Reported | Projected for Next Year | ||
| Short and Long Term Debt Total | 492 K | 777 K | |
| Net Debt | -13.1 M | -12.4 M | |
| Short Term Debt | 128.3 K | 121.9 K | |
| Long Term Debt | 43.2 K | 38.4 K | |
| Short and Long Term Debt | 1.9 M | 1.7 M | |
| Net Debt To EBITDA | 0.78 | 0.82 | |
| Debt To Equity | (8.89) | (8.45) | |
| Debt To Assets | 0.93 | 0.89 | |
| Long Term Debt To Capitalization | (0.24) | (0.23) | |
| Total Debt To Capitalization | 1.32 | 2.59 | |
| Debt Equity Ratio | (8.89) | (8.45) | |
| Debt Ratio | 0.93 | 0.89 | |
| Cash Flow To Debt Ratio | (0.44) | (0.47) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Monogram Orthopaedics Fundamentals Over Time. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monogram Orthopaedics. If investors know Monogram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monogram Orthopaedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share 0.012 | Return On Assets (0.61) | Return On Equity (1.22) |
The market value of Monogram Orthopaedics is measured differently than its book value, which is the value of Monogram that is recorded on the company's balance sheet. Investors also form their own opinion of Monogram Orthopaedics' value that differs from its market value or its book value, called intrinsic value, which is Monogram Orthopaedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monogram Orthopaedics' market value can be influenced by many factors that don't directly affect Monogram Orthopaedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monogram Orthopaedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Monogram Orthopaedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monogram Orthopaedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.